跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALS-2/3
首页
药物
ALS-2/3
ALS-2/3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
THE PEPTIDOMIMETIC COMPOUND (R)-2-AMINO-N-((S)-L-(((S)-5-AMINO-L-(3-BENZYL-1,2,4-OXADIAZOL-5-YL)PENTYL)AMINO)-3-(4-HYDROXY-2,6-DIMETHYLPHENYL)-1-OXOPROPAN-2-YL)-5-GUANIDINOPENTANAMIDE FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
EP 3986401 B1
申请人: STEALTH BIOTHERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
9 件公开
PHARMACEUTICAL AGENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR SUPPRESSING DISEASE PROGRESS THEREOF
US 2014228420 A1
申请人: YONEOKA TAKATOMO
优先权: 2011
CN
EP
US
WO
8 件公开
LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
US 2023090069 A1
申请人: CENTRE HOSPITALIER UNIV DE NIMES
优先权: 2020
EP
US
WO
5 件公开
ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL
US 2010075926 A1
申请人: TSAI LI-HUEI
优先权: 2008
CN
US
WO
4 件公开
Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
US 10898458 B2
申请人: MICELLE BIOPHARMA INC
优先权: 2017
US
4 件公开
COMBINATION THERAPY OF TRADITIONAL CHINESE AND MODERN MEDICINE FOR TREATMENT OF PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
US 20260021150 A1
申请人: INTEGRATED MOLECULAR MEDICINE LTD
优先权: 2024
CN
US
WO
3 件公开
Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors
CN 1466576 A
申请人: ENZYME SYST PROD INC
优先权: 2000
CN
US
2 件公开
Model for simulating ALS constructed based on CASP4 and its construction method
US 20260072015 A1
申请人: UNIV JINAN
优先权: 2024
CN
US
2 件公开
Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
US 2003149046 A1
申请人: FUJIWARA JUNYA
优先权: 2000
US
2 件公开
Methods and materials for detecting C9ORF72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or C9ORF72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis
US 9448232 B2
申请人: MAYO FOUNDATION
优先权: 2014
US
2 件公开
第 1 / 5 页
上一页
下一页
药物
反馈